CompletedNot Applicable

Single Session Intervention to Promote Hope

United States97 participantsStarted 2024-05-07

Plain-language summary

The purpose of this study is to develop a brief, self-guided single-session intervention (SSI) that targets the development of, or increase in, hope, and pilot test it for the primary outcomes of feasibility, acceptability/likeability, safety, and changes in hope, and the secondary outcomes of self-worth, empowerment, and emotional wellbeing among women experiencing intimate partner violence (IPV). The study will be conducted in 2 stages: intervention development (Intervention Development Stage), and pilot testing the intervention (Pilot Stage). The focus of this registration is the Pilot Stage.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Pilot Stage: * Self-identify as a woman (cis- or trans-gender woman) * Currently in a relationship of at least 3 months duration in which they have experienced physical IPV by a male partner * Have a smartphone that is compatible with the MyCap app to be able to participate in daily surveys. Exclusion Criteria: Pilot Stage: * Have experienced significant psychiatric instability based on self-reported inpatient psychiatric hospitalization in the past 3 months * Reports having a conservator of person * Not comfortable conversing, reading, or writing in English * Participated in a Listening Session in the development phase of this study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Feasibility assessed by percent enrolled

Timeframe: up to one month

Feasibility assessed by time to complete

Timeframe: up to one month

Feasibility assessed by post-intervention survey/process supplement

Timeframe: up to one month

Acceptability/likability assessed using the Program Feeback Scale

Timeframe: up to one month

Safety assessed using end of study survey

Timeframe: up to one month

Change in Hope assessed using Herth Hope Index

Timeframe: baseline (pre intervention) and up to one month (post intervention)

Change in Hope assessed using Trait Hope Scale

Timeframe: baseline (pre intervention) and up to one month (post intervention)

Trial details

NCT IDNCT06375876

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-15

View on ClinicalTrials.gov More Domestic Violence trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Feasibility assessed by percent enrolled

Timeframe: up to one month

Feasibility assessed by time to complete

Timeframe: up to one month

Feasibility assessed by post-intervention survey/process supplement

Timeframe: up to one month

Acceptability/likability assessed using the Program Feeback Scale

Timeframe: up to one month

Safety assessed using end of study survey

Timeframe: up to one month

Change in Hope assessed using Herth Hope Index

Timeframe: baseline (pre intervention) and up to one month (post intervention)

Change in Hope assessed using Trait Hope Scale

Timeframe: baseline (pre intervention) and up to one month (post intervention)